Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Naive Patients”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00543530
What this trial is testing

Pediatric Expanded Access Program-Oral Solution (0831-908)

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)Study completedNCT00089999
What this trial is testing

Lapatinib In Chemotherapy-Naive Or Metastatic Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 138
Testing effectiveness (Phase 2)Study completedNCT02013206
What this trial is testing

Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer Naive to Chemotherapy

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 52
Large-scale testing (Phase 3)Study completedNCT00043927
What this trial is testing

Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults

Who this might be right for
Small Cell Lung Cancer
GlaxoSmithKline 760
Large-scale testing (Phase 3)Study completedNCT00120536
What this trial is testing

Efficacy and Safety of Three Doses of Vildagliptin in Drug Naive Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Novartis 288
Large-scale testing (Phase 3)Study completedNCT01399619
What this trial is testing

Phase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Immunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4)

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 310
Testing effectiveness (Phase 2)Study completedNCT00882908
What this trial is testing

TMC435 in Combination With Pegylated Interferon Alp\Fa-2a and Ribavirin in Patients Infected With Genotype 1 Hepatitis C Virus Who Never Received Treatment

Who this might be right for
Hepatitis C
Tibotec Pharmaceuticals, Ireland 386
Testing effectiveness (Phase 2)Study completedNCT00004187
What this trial is testing

Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Swiss Cancer Institute
Post-approval studies (Phase 4)Study completedNCT00751114
What this trial is testing

Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-naive Patients

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 515
Testing effectiveness (Phase 2)Study completedNCT00993148
What this trial is testing

Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1

Who this might be right for
HIV-1 InfectionHIV Infections
Northwestern University 25
Not applicableWithdrawnNCT00571714
What this trial is testing

Pilot Comparison of Standard Antiviral Therapy With and Without 12 Weeks of Betaine in Genotype 1 Naive Patients

Who this might be right for
Chronic Hepatitis C
University of Nebraska
Large-scale testing (Phase 3)Study completedNCT00002178
What this trial is testing

A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients

Who this might be right for
HIV Infections
Hoffmann-La Roche 375
Testing effectiveness (Phase 2)Study completedNCT01329978
What this trial is testing

Sofosbuvir With Pegylated Interferon and Ribavirin Hepatitis C Virus (HCV) Genotypes 1,4,5,6

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 332
Post-approval studies (Phase 4)Ended earlyNCT00255008
What this trial is testing

Peg-Intron and Rebetol Therapy in Treatment of Naive Hepatitis C Patients: A Comparison of Race and Genotype on Treatment Outcome (Study P04212)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 121
Testing effectiveness (Phase 2)UnknownNCT00332176
What this trial is testing

Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
BioWest Therapeutics Inc 50
Large-scale testing (Phase 3)Study completedNCT02504268
What this trial is testing

Effects of Abatacept in Patients With Early Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 994
Large-scale testing (Phase 3)Study completedNCT03069352
What this trial is testing

Venetoclax in Combination With Low Dose Cytarabine Versus Low Dose Cytarabine Alone in Treatment Naive Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy

Who this might be right for
Acute Myeloid Leukemia (AML)
AbbVie 211
Large-scale testing (Phase 3)Study completedNCT01853826
What this trial is testing

An Open Label Trial of Afatinib (Giotrif) in Treatment-naive (1st Line) or Chemotherapy Pre-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 481
Post-approval studies (Phase 4)UnknownNCT00005017
What this trial is testing

Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment

Who this might be right for
HIV Infections
Glaxo Wellcome 300
Not applicableStudy completedNCT01764321
What this trial is testing

Noninterventional Examination of Subcutaneous (sc) Tumor Necrosis Factor (TNF) Inhibitors

Who this might be right for
Rheumatoid Arthritis
UCB Pharma SA 1,723
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation